Cite
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
MLA
Geraint T. Williams, et al. A Feasibility Study Testing Four Hypotheses with Phase II Outcomes in Advanced Colorectal Cancer (MRC FOCUS3): A Model for Randomised Controlled Trials in the Era of Personalised Medicine? Apr. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cff73b2cbc37e2e73c551850137aa559&authtype=sso&custid=ns315887.
APA
Geraint T. Williams, Richard H. Wilson, Graham R. Taylor, Rachel Butler, David Fisher, Susan D. Richman, S Kenny, Dominic Furniss, Rajarshi Roy, Matthew T. Seymour, Angela M. Meade, Elizabeth Hodgkinson, Richard Kaplan, Catherine Sampson, Malcolm Pope, Richard Adams, J.K. Pope, Tim Maughan, M.K. Parmar, … Annmarie Nelson. (2014). A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
Chicago
Geraint T. Williams, Richard H. Wilson, Graham R. Taylor, Rachel Butler, David Fisher, Susan D. Richman, S Kenny, et al. 2014. “A Feasibility Study Testing Four Hypotheses with Phase II Outcomes in Advanced Colorectal Cancer (MRC FOCUS3): A Model for Randomised Controlled Trials in the Era of Personalised Medicine?,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cff73b2cbc37e2e73c551850137aa559&authtype=sso&custid=ns315887.